Russell J. Cox

2014 - Jazz Pharmaceuticals

In 2014, Russell J. Cox earned a total compensation of $5.5M as Executive Vice President and COO at Jazz Pharmaceuticals, a 131% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$320,000
Option Awards$1,991,469
Salary$493,462
Stock Awards$2,681,998
Other$11,759
Total$5,498,688

Cox received $2.7M in stock awards, accounting for 49% of the total pay in 2014.

Cox also received $320K in non-equity incentive plan, $2M in option awards, $493.5K in salary and $11.8K in other compensation.

Rankings

In 2014, Russell J. Cox's compensation ranked 1,361st out of 13,032 executives tracked by ExecPay. In other words, Cox earned more than 89.6% of executives.

ClassificationRankingPercentile
All
1,361
out of 13,032
90th
Division
Manufacturing
489
out of 4,965
90th
Major group
Chemicals And Allied Products
155
out of 1,690
91st
Industry group
Drugs
121
out of 1,369
91st
Industry
Pharmaceutical Preparations
106
out of 1,042
90th
Source: SEC filing on June 20, 2017.

Cox's colleagues

We found five more compensation records of executives who worked with Russell J. Cox at Jazz Pharmaceuticals in 2014.

2014

Bruce Cozadd

Jazz Pharmaceuticals

Chief Executive Officer

2014

Suzanne Hooper

Jazz Pharmaceuticals

Executive Vice President and GC

2014

Matthew Young

Jazz Pharmaceuticals

Chief Financial Officer

2014

Michael Miller

Jazz Pharmaceuticals

Senior Vice President, U.S. Commercial

2014

Kathryn Falberg

Jazz Pharmaceuticals

Chief Financial Officer

News

You may also like